Related Experiment Video
Updated: Jul 1, 2026

16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
26.4K
Artificial Intelligence-Guided Gut-Microenvironment-Triggered Imaging Sensor Reveals Potential Indicators of
Yiwei Li1,2, Hong-Xia Ren3, Chong-Yung Chi2
1Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610000, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|April 3, 2024
Summary
A novel AI-guided sensor detects Parkinson's disease (PD) by analyzing gut alpha-synuclein (α-Syn). This non-invasive approach enables early diagnosis and personalized treatment strategies for PD.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Microbiology
Background:
- The gut-brain axis plays a critical role in Parkinson's disease (PD) pathogenesis.
- Gut microbiota dysregulation is linked to PD development.
- There is a need for non-invasive gut-derived biomarkers for early PD diagnosis.
Purpose of the Study:
- To develop an artificial intelligence-guided imaging sensor for non-invasive, early screening of Parkinson's disease.
- To analyze gut alpha-synuclein (α-Syn) levels for PD prediction.
- To explore the integration of AI and advanced sensors for disease monitoring.
Main Methods:
- Development of an artificial intelligence-guided gut-microenvironment-triggered imaging sensor (Eu-MOF@Au-Aptmer).
- Utilizing deep learning algorithms to analyze α-Syn in the gut.
- Monitoring changes in α-Syn for PD onset prediction.
Main Results:
- The developed sensor achieves non-invasive and accurate screening for various stages of PD.
- Monitoring α-Syn levels allows for high-accuracy prediction of PD onset.
- The sensor demonstrates the potential for early intervention and personalized PD treatment.
Conclusions:
- The AI-guided sensor offers a promising tool for early Parkinson's disease diagnosis.
- This technology highlights the potential of AI and advanced sensors in disease monitoring and prediction.
- Integration of gut microbiota analysis and AI could revolutionize PD management.

